Decreasing cancer risk associated with inflammatory bowel disease

July 9, 2012

Inflammatory bowel disease is caused by chronic inflammation , which leads to damage of the intestinal epithelium.

Patients with have an elevated risk for developing colorectal cancer because of this .

In an effort to develop strategies to break the cycle of inflammation, Dr. Brent Polk and colleagues at the University of Southern California in Los Angeles examined two mouse models of colorectal cancer.

Their work shows that inactivating a key receptor, known as epidermal growth factor receptor, increases the frequency and severity of colorectal tumors.

Though epidermal growth factor has well-defined roles in promoting tumor growth, the Polk team now finds that epidermal growth factor receptor can ameliorate the response to chronic inflammation and reduces tumor development by fine-tuning inflammation and the generation of intestinal epithelium.

Their results suggest that promoting epidermal growth factor activity in patients with inflammatory bowel disease could decrease long-term by reducing inflammation.

Explore further: Protein from probiotic bacteria may alleviate inflammatory bowel disorders

More information: View this article at: www.jci.org/articles/view/62888?key=ab673ae8215aaf449677

Related Stories

Recommended for you

Study offers new insight into powerful inflammatory regulator

May 1, 2017

A new study in mice reveals how a protein called Brd4 boosts the inflammatory response—for better and for worse, depending on the ailment. The study is the first to show that this protein, while problematic in some circumstances, ...

Researchers find molecular trigger for brain inflammation

April 27, 2017

Brain inflammation is a key component of multiple sclerosis, Alzheimer's, Parkinson's, ALS, and most other major neurodegenerative diseases. How inflammation starts, how it's sustained, and how it contributes to these diseases ...

Bitter taste receptors hold key to treating asthma

April 27, 2017

One in nine Australians, among more than 300 million people worldwide, suffer from asthma. They experience a wide range of debilitating, even life-threatening respiratory symptoms from a disease that can be controlled but ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.